Roche Holding AG
SIX:ROG
Roche Holding AG
SIX:ROG
Price:
222.6 CHF
0.72%
Updated:
Apr 29, 2024
Roche Holding AG
Research & Development
|
Roche Holding AG
Research & Development Peer Comparison
Comparables:
NOVN
NLSP
S
SDZ
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Roche Holding AG
SIX:ROG
|
Research & Development
-CHf13.2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
|
|
Novartis AG
SIX:NOVN
|
Research & Development
-$8.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Research & Development
-$9m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Research & Development
-$831m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Research & Development?
Research & Development
-13.2B
CHF
-13.2B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Research & Development amounts to -13.2B CHF.
What is Roche Holding AG's Research & Development growth rate?
Research & Development CAGR 10Y
-4%
-4%
Over the last year, the Research & Development growth was 6%. The average annual Research & Development growth rates for Roche Holding AG have been -3% over the past three years , -4% over the past five years , and -4% over the past ten years .
You don't have any saved screeners yet
